Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Liposarcoma × cabazitaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 19 Neoplasm Metastasis 7 Prostate Cancer Metastatic 4 Neoplasms 4 Recurrence 3 Carcinoma, Transitional Cell 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Carcinoma, Squamous Cell 2 Solid Cancer 1 Penile Neoplasms 1 Ovarian Neoplasms 1 Neoplastic Cells, Circulating 1 Malignant Solid Tumor - Malignant Nervous System Neoplasm 1 Liposarcoma 1 Head and Neck Neoplasms 1 Glioblastoma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Bone Metastatic Prostate Cancer 1 Advanced Solid Tumor 1

Interventions

Doxorubicin 13 Ifosfamide 8 Trabectedin 7 Radiotherapy 7 pazopanib 3 Filgrastim 3 temsirolimus 2 ribociclib 2 pegfilgrastim 2 eribulin 2 cixutumumab 2 brigimadlin 2 belinostat 2 Sunitinib 2 Radiotherapy, Conformal 2 Imatinib Mesylate 2 Gemcitabine 2 Dexamethasone 2 Cyclophosphamide 2 soblidotin 1 sitravatinib 1 siremadlin 1 selinexor 1 sargramostim 1 saracatinib 1 romidepsin 1 ridaforolimus 1 regorafenib 1 perifosine 1 pembrolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01913652 2021-09-14

Ph II Cabazitaxel DD Liposarcoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed

Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡